Publikationen, an denen er mitarbeitet ANGEL SALGADO BARREIRA (12)

2024

  1. Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient

    Inflammopharmacology, Vol. 32, Núm. 3, pp. 1805-1815

  2. Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 539-546

  3. Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study

    International Journal of Neuropsychopharmacology, Vol. 27, Núm. 4

  4. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study

    Inflammopharmacology, Vol. 32, Núm. 4, pp. 2305-2315

  5. The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study

    Inflammopharmacology

2023

  1. Colchicine and risk of hospitalization due to COVID-19: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 2

  2. Effect of Previous Anticoagulant Treatment on Risk of COVID-19

    Drug Safety, Vol. 46, Núm. 3, pp. 273-281

  3. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342

  4. Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 7

  5. RE: Colchicine and risk of hospitalization due to COVID-19: A population-based study

    Journal of Medical Virology

  6. Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: A population-based study

    European Neuropsychopharmacology, Vol. 71, pp. 96-108

2021

  1. A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users

    Scientific Reports, Vol. 11, Núm. 1